Overview
A leading medical learning platform partnered with a pharmaceutical client to run two feedback surveys for healthcare professionals (HCPs) on:
- A triple-combination anti-diabetic tablet (Glimepiride, Metformin, Voglibose).
- An alpha-blocker medication used for hypertension and benign prostatic hyperplasia.
The goal was to gather real-time insights, understand prescribing patterns, and improve doctor engagement.
Objective
- Collect 100+ responses per survey within one month.
- Strengthen product perception through direct physician feedback.
- Reach key specialties: Consulting Physicians, Endocrinologists, Diabetologists, and Nephrologists.
Methodology
The platform executed an omni-channel promotion using:
- Email campaigns
- SMS reminders
- Google Form surveys
Each specialty received tailored communication 2–4 times a month, ensuring repeated visibility and higher response rates.
Performance Overview
| Survey Type | Reach | Impressions | Responses |
|---|---|---|---|
| Anti-Diabetic Combination | 79,542 | 184,734 | 115 |
| Alpha-Blocker Tablet | 74,287 | 167,802 | 111 |
Key Outcomes
- Achieved the target of 100+ responses for each survey.
- Recorded 2% CTR and 4% conversion rate, showing strong HCP interest.
- Over 3,000+ interactions across both surveys.
Participation Breakdown
Anti-Diabetic Survey
- 46% Consulting Physicians
- 31% Diabetologists
- 23% Endocrinologists
Alpha-Blocker Survey
- 52% Consulting Physicians
- 48% Nephrologists
Conclusion
The campaign demonstrated how strategic, multi-channel outreach can effectively engage doctors and generate meaningful feedback. With timely execution and targeted messaging, both surveys surpassed their response goals and provided valuable insights for future marketing and educational initiatives.
